首页> 外文会议>Thailand International Nanotechnology Conference >Hepatocellular Carcinoma Biomarker detection by Surface Plasmon Resonance sensor
【24h】

Hepatocellular Carcinoma Biomarker detection by Surface Plasmon Resonance sensor

机译:表面等离子体共振传感器检测肝细胞癌生物标志物

获取原文

摘要

Hepatocellular carcinoma is a one of the most common cancer in the world and the third cause of cancer-related death. The recommended screening test for patients are the detection of serum α-fetoprotein (AFP) levels and an abdominal ultrasound every 6 months to detect HCC. To inform stage of the diasease, we investigate the alpha fetoprotein (AFP) which is a major HCC biomarker by using surface Plasmon resonance (SPR) technique. SPR is an optical biosensor, nanoscale detectable and highly sensitive technique which is suitable for an early detection application. The interaction of anti-AFP antibody and AFP antigen was created via sandwich assay on carboxy dextran sensor surface. To get the enhancing signal, effect of electrostatics and binding capacity of immobilization were studied. Additionally, we found that the higher enhancing signal is done by superimposing of anti-IgG on the system. The result was shown that AFP concentration was measured in a range of the HCC biomarker with the detection limit of 50 ng/ml and 20 ng/ml by sandwich assay and an anti-IgG enhancement, respectively. Moreover, the serum testing was studied for deveopment in clinical diagnostic further.
机译:肝细胞癌是世界上最常见的癌症之一,以及癌症相关死亡的第三个原因。推荐的患者筛查试验是检测血清α-胎儿(AFP)水平和每6个月腹部超声以检测HCC。为了告知初期的杀酶,我们研究了通过使用表面等离子体共振(SPR)技术的主要HCC生物标志物的α胎儿蛋白(AFP)。 SPR是一种光学生物传感器,纳米级可检测和高敏感技术,适用于早期检测应用。通过夹心测定在羧基葡聚糖传感器表面上通过夹心测定产生抗AFP抗体和AFP抗原的相互作用。为了获得增强信号,研究了静电和固定能力的效果。另外,我们发现通过在系统上叠加抗IgG来完成更高的增强信号。结果表明,通过夹层测定和抗IgG增强,在HCC生物标志物的一系列HCC生物标志物中测量AFP浓度和20ng / ml的检测限。此外,进一步研究临床诊断中的血清试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号